tiprankstipranks
U.s. Physical Therapy (USPH)
NYSE:USPH
US Market
Want to see USPH full AI Analyst Report?

US Physical Therapy (USPH) Ratios

138 Followers

US Physical Therapy Ratios

USPH's free cash flow for Q1 2026 was $0.14. For the 2026 fiscal year, USPH's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.19 1.01 1.18 2.28 1.30
Quick Ratio
1.19 1.01 1.18 2.28 1.30
Cash Ratio
0.24 0.26 0.36 1.50 0.37
Solvency Ratio
0.05 0.09 0.11 0.09 0.12
Operating Cash Flow Ratio
0.71 0.54 0.64 0.80 0.68
Short-Term Operating Cash Flow Coverage
1.56 1.44 6.81 10.66 7.44
Net Current Asset Value
$ -320.08M$ -293.82M$ -270.84M$ -111.63M$ -262.32M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.35 0.25 0.26 0.34
Debt-to-Equity Ratio
0.77 0.89 0.60 0.54 0.94
Debt-to-Capital Ratio
0.44 0.47 0.38 0.35 0.48
Long-Term Debt-to-Capital Ratio
0.29 0.36 0.23 0.23 0.36
Financial Leverage Ratio
2.65 2.53 2.39 2.09 2.72
Debt Service Coverage Ratio
1.37 1.46 3.80 3.66 4.69
Interest Coverage Ratio
8.75 8.50 7.89 5.60 9.83
Debt to Market Cap
0.26 0.27 0.11 0.11 0.17
Interest Debt Per Share
24.58 28.68 20.13 18.88 23.19
Net Debt to EBITDA
3.18 3.56 2.92 1.42 3.47
Profitability Margins
Gross Profit Margin
20.44%20.15%18.46%20.09%20.25%
EBIT Margin
11.33%11.17%10.16%9.70%11.09%
EBITDA Margin
14.42%14.04%12.94%12.30%13.76%
Operating Profit Margin
11.96%10.30%9.42%8.61%10.27%
Pretax Profit Margin
9.74%9.96%8.97%8.16%10.05%
Net Profit Margin
0.16%1.93%3.94%2.43%5.11%
Continuous Operations Profit Margin
7.23%7.43%6.79%6.15%7.85%
Net Income Per EBT
1.66%19.36%43.95%29.72%50.87%
EBT Per EBIT
81.46%96.74%95.25%94.84%97.83%
Return on Assets (ROA)
0.10%1.25%2.27%1.47%3.29%
Return on Equity (ROE)
0.24%3.16%5.41%3.08%8.95%
Return on Capital Employed (ROCE)
7.75%7.55%6.01%5.82%7.35%
Return on Invested Capital (ROIC)
5.49%5.37%4.34%4.18%5.45%
Return on Tangible Assets
0.34%4.45%8.24%3.88%11.07%
Earnings Yield
0.12%1.27%1.98%1.11%2.69%
Efficiency Ratios
Receivables Turnover
7.54 12.16 7.84 11.66 8.06
Payables Turnover
85.85 102.93 92.22 123.98 67.82
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3.88 2.88 4.04 4.67 4.33
Asset Turnover
0.59 0.65 0.58 0.61 0.64
Working Capital Turnover Ratio
64.08 70.20 8.81 7.71 29.53
Cash Conversion Cycle
44.16 26.48 42.62 28.36 39.89
Days of Sales Outstanding
48.41 30.03 46.58 31.30 45.27
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
4.25 3.55 3.96 2.94 5.38
Operating Cycle
48.41 30.03 46.58 31.30 45.27
Cash Flow Ratios
Operating Cash Flow Per Share
5.52 4.95 4.97 5.78 4.51
Free Cash Flow Per Share
4.41 4.02 4.36 5.12 3.87
CapEx Per Share
1.11 0.93 0.61 0.66 0.64
Free Cash Flow to Operating Cash Flow
0.80 0.81 0.88 0.89 0.86
Dividend Paid and CapEx Coverage Ratio
1.89 1.81 2.10 2.45 1.98
Capital Expenditure Coverage Ratio
4.97 5.33 8.16 8.82 7.10
Operating Cash Flow Coverage Ratio
0.23 0.18 0.25 0.32 0.20
Operating Cash Flow to Sales Ratio
0.11 0.10 0.11 0.14 0.11
Free Cash Flow Yield
7.00%5.15%4.92%5.50%4.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
807.32 78.68 50.50 90.06 37.22
Price-to-Sales (P/S) Ratio
1.31 1.52 1.99 2.18 1.90
Price-to-Book (P/B) Ratio
2.03 2.49 2.73 2.78 3.33
Price-to-Free Cash Flow (P/FCF) Ratio
14.29 19.43 20.32 18.18 20.92
Price-to-Operating Cash Flow Ratio
11.38 15.79 17.83 16.12 17.97
Price-to-Earnings Growth (PEG) Ratio
-10.48 -3.45 1.15 -1.46 -1.45
Price-to-Fair Value
2.03 2.49 2.73 2.78 3.33
Enterprise Value Multiple
12.27 14.36 18.30 19.19 17.29
Enterprise Value
1.29B 1.58B 1.59B 1.43B 1.32B
EV to EBITDA
12.27 14.36 18.30 19.19 17.29
EV to Sales
1.77 2.02 2.37 2.36 2.38
EV to Free Cash Flow
19.30 25.83 24.18 19.64 26.17
EV to Operating Cash Flow
15.41 20.99 21.22 17.41 22.48
Tangible Book Value Per Share
-7.44 -6.26 -5.80 2.32 -9.11
Shareholders’ Equity Per Share
30.92 31.40 32.46 33.56 24.32
Tax and Other Ratios
Effective Tax Rate
0.26 0.25 0.24 0.25 0.22
Revenue Per Share
48.08 51.47 44.57 42.63 42.60
Net Income Per Share
0.08 0.99 1.76 1.03 2.18
Tax Burden
0.02 0.19 0.44 0.30 0.51
Interest Burden
0.86 0.89 0.88 0.84 0.91
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.04 0.00 0.09 0.00 0.08
Stock-Based Compensation to Revenue
<0.01 0.01 0.01 0.01 0.01
Income Quality
2.14 1.29 1.64 2.20 1.35
Currency in USD